38583830|t|Chondroitin sulphate modified MoS2 nanoenzyme with multifunctional activities for treatment of Alzheimer's disease.
38583830|a|Nano-MoS2 exhibit oxidoreductase-like activities, and has been shown to can effectively eliminate excessive intracellular ROS and inhibit Abeta aggregation, thus demonstrating promising potential for anti-Alzheimer's disease (anti-AD) intervention. However, the low water dispersibility and high toxicity of nano-MoS2 limits its further application. In this study, we developed a chondroitin sulphate (CS)-modified MoS2 nanoenzyme (CS@MoS2) by harnessing the excellent biocompatibility of CS and the exceptional activities of nano-MoS2 to explore its potential in anti-AD research. Promisingly, CS@MoS2 significantly inhibited Abeta1-40 aggregation and prevented toxic injury in SH-SY5Y cells caused by Abeta1-40. In addition, CS@MoS2 protected these cells from oxidative stress damage by regulating ROS production, as well as promoting the activities of SOD and GSH-Px. CS@MoS2 also modulated the intracellular Ca2+ imbalance and downregulated Tau hyperphosphorylation by activating GSK-3beta. CS@MoS2 suppressed p-NF-kappaB (p65) translocation to the nucleus by inhibiting MAPK phosphorylation, and modulated the expression of downstream anti- and proinflammatory cytokines. Owing to its multifunctional activities, CS@MoS2 effectively improved spatial learning, memory, and anxiety in D-gal/AlCl3-induced AD mice. Taken together, these results indicate that CS@MoS2 has significant potential for improving the therapeutic efficacy of the prevention and treatment of AD, while also presenting a novel framework for the application of nanoenzymes.
38583830	0	20	Chondroitin sulphate	Chemical	MESH:D002809
38583830	95	114	Alzheimer's disease	Disease	MESH:D000544
38583830	121	125	MoS2	Chemical	MESH:C082964
38583830	238	241	ROS	Chemical	-
38583830	254	259	Abeta	Gene	351
38583830	321	340	Alzheimer's disease	Disease	MESH:D000544
38583830	347	349	AD	Disease	MESH:D000544
38583830	382	387	water	Chemical	MESH:D014867
38583830	412	420	toxicity	Disease	MESH:D064420
38583830	429	433	MoS2	Chemical	MESH:C082964
38583830	496	516	chondroitin sulphate	Chemical	MESH:D002809
38583830	518	520	CS	Chemical	MESH:D002809
38583830	548	555	CS@MoS2	Chemical	-
38583830	605	607	CS	Chemical	MESH:D002809
38583830	647	651	MoS2	Chemical	MESH:C082964
38583830	685	687	AD	Disease	MESH:D000544
38583830	711	718	CS@MoS2	Chemical	-
38583830	795	802	SH-SY5Y	CellLine	CVCL:0019
38583830	843	850	CS@MoS2	Chemical	-
38583830	916	919	ROS	Chemical	-
38583830	971	974	SOD	Gene	6647
38583830	987	994	CS@MoS2	Chemical	-
38583830	1028	1032	Ca2+	Chemical	-
38583830	1061	1064	Tau	Gene	4137
38583830	1100	1109	GSK-3beta	Gene	2932
38583830	1111	1118	CS@MoS2	Chemical	-
38583830	1132	1141	NF-kappaB	Gene	4790
38583830	1143	1146	p65	Gene	5970
38583830	1266	1281	proinflammatory	Disease	
38583830	1334	1341	CS@MoS2	Chemical	-
38583830	1393	1400	anxiety	Disease	MESH:D001007
38583830	1404	1409	D-gal	Chemical	-
38583830	1410	1415	AlCl3	Chemical	MESH:D000077410
38583830	1424	1426	AD	Disease	MESH:D000544
38583830	1427	1431	mice	Species	10090
38583830	1477	1484	CS@MoS2	Chemical	-
38583830	1585	1587	AD	Disease	MESH:D000544
38583830	Positive_Correlation	MESH:D000077410	MESH:D000544
38583830	Negative_Correlation	MESH:D002809	MESH:D000544
38583830	Negative_Correlation	MESH:C082964	351
38583830	Negative_Correlation	MESH:C082964	MESH:D000544
38583830	Association	2932	4137

